Attached files
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with this Quarterly Report of MusclePharm Corporation
(the “Company”), on Form 10-Q for the period ended
March 31, 2019, as filed with the U.S. Securities and Exchange
Commission on the date hereof (the “Report”), I, Ryan
Drexler, Principal Executive Officer of the Company, certify
pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to
Section. 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and
|
|
(2)
|
The
information contained in the Report, fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
|
|
|
|
Date:
August 24, 2020
|
|
By:
|
/s/
Ryan Drexler
|
|
|
|
Ryan
Drexler
Chief
Executive Officer
(Principal
Executive Officer)
|